---
figid: PMC4471797__cas0106-0665-f1
figtitle: Wnt/Beta-catenin signaling pathway
organisms:
- Homo sapiens
- Mus musculus
- Lareunionomyces loeiensis
pmcid: PMC4471797
filename: cas0106-0665-f1.jpg
figlink: /pmc/articles/PMC4471797/figure/fig01/
number: F1
caption: Wnt/β-catenin signaling pathway. In the absence of Wnt, in the “Wnt signal-off”
  state (left panel), the β-catenin destruction complex is polyubiquitinated by β-transducin
  repeat-containing protein (β-TrCP) and phosphorylated β-catenin (β-Cat) is then
  degraded by the proteasome. In the presence of Wnt, in the “Wnt signal-on” state
  (right panel), phosphorylation of β-catenin is suppressed and β-catenin escapes
  from degradation. Free cytoplasmic β-catenin translocates to the nucleus and forms
  a complex with T-cell factor (TCF)/lymphocyte enhancer factor (LEF). The β-catenin/TCF
  complex activates the transcription of target genes including cyclin D1 and c-myc.
  APC, adenomatous polyposis coli; BCL9, B-cell chronic leukocytic leukemia/lymphoma
  9; CBP, c-AMP response element binding protein-binding protein; CK1α, casein kinase
  1α; Dkk, Dickkopf; Dvl, dishevelled; Fz, Frizzled; HDAC, histone deacetylase; LRP5/6,
  lipoprotein receptor-related protein 5/6; P, phosphorylation; PYG, pygopus; SFRP,
  soluble frizzled-related protein; Ub, ubiquitination; WIF-1, Wnt inhibitory factor-1.
papertitle: Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.
reftext: Eishi Ashihara, et al. Cancer Sci. 2015 Jun;106(6):665-671.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9455807
figid_alias: PMC4471797__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC4471797__F1
ndex: 17ac6f1b-defd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4471797__cas0106-0665-f1.html
  '@type': Dataset
  description: Wnt/β-catenin signaling pathway. In the absence of Wnt, in the “Wnt
    signal-off” state (left panel), the β-catenin destruction complex is polyubiquitinated
    by β-transducin repeat-containing protein (β-TrCP) and phosphorylated β-catenin
    (β-Cat) is then degraded by the proteasome. In the presence of Wnt, in the “Wnt
    signal-on” state (right panel), phosphorylation of β-catenin is suppressed and
    β-catenin escapes from degradation. Free cytoplasmic β-catenin translocates to
    the nucleus and forms a complex with T-cell factor (TCF)/lymphocyte enhancer factor
    (LEF). The β-catenin/TCF complex activates the transcription of target genes including
    cyclin D1 and c-myc. APC, adenomatous polyposis coli; BCL9, B-cell chronic leukocytic
    leukemia/lymphoma 9; CBP, c-AMP response element binding protein-binding protein;
    CK1α, casein kinase 1α; Dkk, Dickkopf; Dvl, dishevelled; Fz, Frizzled; HDAC, histone
    deacetylase; LRP5/6, lipoprotein receptor-related protein 5/6; P, phosphorylation;
    PYG, pygopus; SFRP, soluble frizzled-related protein; Ub, ubiquitination; WIF-1,
    Wnt inhibitory factor-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wif1
  - Cdh1
  - Fzr1
  - Dvl1
  - Csnk1a1
  - Gsk3b
  - Axin1
  - Apc
  - Btrc
  - Ccnd1
  - Myc
  - Nol3
  - Bcl9
  - Crebbp
  - Pag1
  - Cytip
  - Ep300
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - WIF1
  - CDH1
  - FZR1
  - PDIA6
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - KRT10
  - CSNK1A1
  - GSK3B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - BTRC
  - CCND1
  - MYC
  - BCL9
  - PYGB
  - PYGL
  - PYGM
  - HNF4A
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - EP300
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - Cancer
---
